CasNo.1118767-15-9,Semaglutide side chain,(1118767-15-9) Suppliers

1 Gram	Negotiable

Min.Order :1 Gram
Purity: ≥95%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Fmoc-L-Lys[OctotBu)-Glu-(otBu)-AEEA-AEEA]-OSu Semaglutide sidechain high purity Fmoc-L-Lys[OctotBu)-Glu-(otBu)-AEEA-AEEA]-OSu

Quick Details

Appearance:White to light yellow viscous liquid
Application:medical intermediate
PackAge:inside: fluorinated bottle Outside: paper drum
ProductionCapacity:more than 10|Kilogram|Month
Storage:
Transportation:CIF by air or DAP by courier, FOB,EX works etc.

Superiority:

We have produced this product many years and now got scale production .Purity can reach more than 98%.

The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).

Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.

Details:

With years of efforts, we can produce Semaglutide side chain 10kg per batch.

The purity of our products is more than 95%, the single impurity is less than 0.5%, and the isomer impurity is less than 0.1%, which helps customers improve the quality of final products. We have carried out a complete impurity research and stability research, and obtained the main impurity reference substance, which can save a lot of R & D time for our customers.

The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).

Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.